$EOLS
Evolus, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Newport Beach, CA
EOLS chart
What traders are saying about $EOLS
Latest postsEvolus, Inc. news
- Law firm probes Evolus over FDA warning on misl...
Pluang ·
- Evolus, Inc. Common Stock Estimates – NASDAQ:EOLS
TradingView ·
- Bronstein, Gewirtz & Grossman, LLC Encourages Evolus, Inc. (EOLS)
The National Law Review ·
- (EOLS) and the Role of Price-Sensitive Allocations
Stock Traders Daily ·
- Evolus to Report Third Quarter Financial Results on November 4, 2026
Yahoo Finance ·
- Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program
Yahoo Finance ·
- UTMD Trades at a Premium to the Industry: How to Play the Stock?
Yahoo Finance ·
- FDA Flags Evolus’ Jeuveau Instagram Promotion As Misleading, Seeks Corrective Action
stocktwits.com ·
- Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes
Yahoo Finance ·
- Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future
Yahoo Finance ·
- A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
Yahoo Finance ·
- Telix Appoints David Gill as Chair
Yahoo Finance ·
Evolus, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $297.2M | $266.3M | $202.1M | $148.6M |
| Net income | -$51.6M | -$50.4M | -$61.7M | -$74.4M |
| Diluted EPS | $-0.80 | $-0.81 | $-1.08 | $-1.33 |
| Total assets (year end) | $225.9M | $232.6M | $189.0M | $178.0M |
| Cash and equivalents (year end) | $53.8M | $87.0M | $62.8M | $53.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Evolus, Inc.
- Ticker
- EOLS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Newport Beach, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1570562
- Former names
- Evolus, Inc.
Frequently asked questions
What exchange is Evolus, Inc. listed on?
Evolus, Inc. trades on the Nasdaq under the ticker symbol EOLS.
What industry is Evolus, Inc. in?
Evolus, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Evolus, Inc. headquartered?
Evolus, Inc.'s business address on file with the SEC is in Newport Beach, CA.
When does Evolus, Inc.'s fiscal year end?
Evolus, Inc.'s fiscal year ends on December 31.
How much revenue did Evolus, Inc. report?
Evolus, Inc. reported $297.2M in revenue for calendar year 2025, according to its SEC filings.